CoChat

Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes

Okon, Elena B., Chung, Ada W.Y., Zhang, Hongbin, Laher, Ismail, van Breemen, Cornelis · 2007 · Canadian Journal of Physiology and Pharmacology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Diabetes mellitus impairs endothelial function, which can be considered as the hallmark in the development of cardiovascular diseases. Hyperglycemia, hyperinsulinemia, and hyperlipidemia are believed to contribute to endothelial dysfunction. In the present study, we investigated the possible links among these plasma metabolic markers and endothelial function in a mouse model during the development of type 2 diabetes. C57BL/6J-Lep ob/ob mice at 8, 12, and 16 weeks were used to study endothelial function during the establishment of type 2 diabetes. Endothelial function was accessed in vitro in the thoracic aorta by measuring acetylcholine (ACh)-stimulated vasodilatation. Blood plasma was obtained for the measurements of glucose, insulin, triglycerides, and cholesterol levels. Correlation and multiple regression analysis revealed strong negative associations between the ACh responsiveness and the plasma levels of glucose, insulin, and lipid profiles at the age of 8 weeks. Associations were observed at neither older age nor in C57BL/6J mice. In conclusion, the increase in plasma levels of glucose, insulin, and lipids is associated with the impairment of the endothelial function during the early stage of the development of type 2 diabetes. The loss of correlation at an older age suggests multifactorial regulation of endothelial function and cardiovascular complications at later stages of the disease.

Overview

Integrity signals

Registry

Crossref · 10.1139/y07-026

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 50

Metadata

Authors
Okon, E. B., Chung, A. W. Y., Zhang, H., Laher, I., & van Breemen, C.
Affiliations
  • University of British Columbia (CA)
  • James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital, 1081 Burrard Street, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada
Venue
Canadian Journal of Physiology and Pharmacology
Published
2007-05
Volume
85
Issue
5
Pages
562-567
ISSN
  • 0008-4212 (ISSN-L)
  • 1205-7541
OpenAlex
W2030698401
Cited by
50
References
42
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 1
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Licence
www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
Locations
  • Canadian Journal of Physiology and Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Association for Institutional Research
  • Heart and Stroke Foundation of British Columbia and Yukon
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
endothelial dysfunction, type 2 diabetes, hyperglycemia, hyperlipidemia, hyperinsulinemia, thoracic aorta, plasma glucose, plasma insulin, plasma lipids, cardiovascular complications
MeSH terms
Acetylcholine, Age Factors, Animals, Aorta, Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Female, Hyperglycemia, Hyperlipidemias, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Regression Analysis, Triglycerides, Vasodilation, Vasodilator Agents, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.